- Home
- IMMP vs PCK Comparison
IMMP vs PCK Comparison
Compare IMMP & PCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- PCK
- Stock Information
- Founded
- IMMP 1987
- PCK 2002
- Country
- IMMP Australia
- PCK United States
- Employees
- IMMP N/A
- PCK N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- PCK Trusts Except Educational Religious and Charitable
- Sector
- IMMP Health Care
- PCK Finance
- Exchange
- IMMP Nasdaq
- PCK Nasdaq
- Market Cap
- IMMP 211.1M
- PCK 172.2M
- IPO Year
- IMMP N/A
- PCK N/A
- Fundamental
- Price
- IMMP $1.89
- PCK $5.50
- Analyst Decision
- IMMP Buy
- PCK
- Analyst Count
- IMMP 2
- PCK 0
- Target Price
- IMMP $8.50
- PCK N/A
- AVG Volume (30 Days)
- IMMP 659.8K
- PCK 79.7K
- Earning Date
- IMMP 05-23-2025
- PCK 01-01-0001
- Dividend Yield
- IMMP N/A
- PCK 4.58%
- EPS Growth
- IMMP N/A
- PCK N/A
- EPS
- IMMP N/A
- PCK N/A
- Revenue
- IMMP $3,019,249.00
- PCK N/A
- Revenue This Year
- IMMP $50.37
- PCK N/A
- Revenue Next Year
- IMMP N/A
- PCK N/A
- P/E Ratio
- IMMP N/A
- PCK N/A
- Revenue Growth
- IMMP 24.11
- PCK N/A
- 52 Week Low
- IMMP $1.32
- PCK $4.85
- 52 Week High
- IMMP $3.34
- PCK $6.33
- Technical
- Relative Strength Index (RSI)
- IMMP 54.39
- PCK 46.50
- Support Level
- IMMP $1.78
- PCK $5.50
- Resistance Level
- IMMP $2.71
- PCK $5.60
- Average True Range (ATR)
- IMMP 0.17
- PCK 0.07
- MACD
- IMMP 0.02
- PCK 0.01
- Stochastic Oscillator
- IMMP 25.45
- PCK 50.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About PCK Pimco California Municipal Income Fund II of Beneficial Interest
PIMCO CA Muni Income Fund II is a closed-ended investment company. Its investment objective is to seek to provide current income exempt from federal and California income tax. The company portfolio of investment comprises of different sector investments such as healthcare, education, property, and others.